Improving acetoin production through construction of a genome-scale metabolic model

Comput Biol Med. 2023 May:158:106833. doi: 10.1016/j.compbiomed.2023.106833. Epub 2023 Mar 31.

Abstract

Acetoin was widely used in food, medicine, and other industries, because of its unique fragrance. Bacillus amyloliquefaciens was recognized as a safe strain and a promising acetoin producer in fermentation. However, due to the complexity of its metabolic network, it had not been fully utilized. Therefore, a genome-scale metabolic network model (iJYQ746) of B. amyloliquefaciens was constructed in this study, containing 746 genes, 1736 reactions, and 1611 metabolites. The results showed that Mg2+, Mn2+, and Fe2+ have inhibitory effects on acetoin. When the stirring speed was 400 rpm, the maximum titer was 49.8 g L-1. Minimization of metabolic adjustments (MOMA) was used to identify potential metabolic modification targets 2-oxoglutarate aminotransferase (serC, EC 2.6.1.52) and glucose-6-phosphate isomerase (pgi, EC 5.3.1.9). These targets could effectively accumulate acetoin by increasing pyruvate content, and the acetoin synthesis rate was increased by 610% and 10%, respectively. This provides a theoretical basis for metabolic engineering to reasonably transform B. amyloliquefaciens and produce acetoin.

Keywords: Acetoin; Bacillus amyloliquefaciens; Genome-scale metabolic network model; Potential targets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetoin* / metabolism
  • Fermentation
  • Metabolic Engineering* / methods
  • Metabolic Networks and Pathways / genetics

Substances

  • Acetoin